Table 1.
Variable | No revision n=917 | Revision n=617 | P-Value | |
---|---|---|---|---|
Age, mean (SD) | 48.8 (10.5) | 49.5 (9.5) | 0.181 | |
BMI, mean (SD) | 25.7 (5.3) | 26.7 (5.1) | <.001 | |
Procedure type | ||||
DTI | 51 (75.0%) | 17 (25.0%) | <.001 | |
TE | 665 (65.7%) | 347 (34.3%) | ||
PTRAM | 31 (59.6%) | 21 (40.4%) | ||
FTRAM | 29 (42.0%) | 40 (58.0%) | ||
DIEP | 99 (40.4%) | 146 (59.6%) | ||
LD | 20 (40.8%) | 29 (59.2%) | ||
SIEA | 22 (56.4%) | 17 (43.6%) | ||
Laterality | ||||
Unilateral | 419 (58.4%) | 299 (41.6%) | 0.287 | |
Bilateral | 498 (61.0%) | 318 (39.0%) | ||
Indication | ||||
Therapeutic | 821 (59.9%) | 550 (40.1%) | 0.808 | |
Prophylactic | 96 (58.9%) | 67 (41.1%) | ||
Timing | ||||
Immediate | 867 (61.1%) | 553 (38.9%) | <.001 | |
Delayed | 50 (43.9%) | 64 (56.1%) | ||
Diabetes | ||||
Yes | 43 (68.3%) | 20 (31.7%) | 0.161 | |
No | 874 (59.4%) | 597 (40.6%) | ||
Radiation | ||||
Before reconstruction | 87 (48.6%) | 92 (51.4%) | <.001 | |
During/after reconstruction | 167 (67.3%) | 81 (32.7%) | ||
None | 663 (59.9%) | 444 (40.1%) | ||
Chemo | ||||
During/after reconstruction | 289 (64.2%) | 161 (35.8%) | 0.022 | |
Not during/after reconstruction | 628 (57.9%) | 456 (42.1%) | ||
Race | ||||
White | 784 (58.8%) | 549 (41.2%) | 0.067 | |
Black | 59 (61.5%) | 37 (38.5%) | ||
Other | 62 (71.3%) | 25 (28.7%) |